Pulmonary hypertension related to chronic lung disease, mainly represented by COPD and
idiopathic pulmonary fibrosis, is associated with a worse outcome when compared with …

Pulmonary vascular and cardiac impairment is increasingly appreciated as a major adverse
factor in the natural history of interstitial lung disease. This clinically orientated review …

Early diagnosis and continuous monitoring of respiratory failure (RF) in the course of the
most prevalent chronic cardio-vascular (CVD) and respiratory diseases (CRD) are a clinical …

Pulmonary hypertension (PH) is an end result of a diverse array of complex clinical
conditions that invoke hemodynamic and pathophysiological changes in the pulmonary …

This study aimed to determine diagnostic and prognostic differences in major forms of
interstitial lung disease using quantitative CT imaging. A retrospective study of 225 subjects …

Combined pulmonary fibrosis and emphysema (CPFE) is a syndrome that predominantly
affects male smokers or ex-smokers and it has a mortality rate of 55% and a median survival …

The field of pulmonary fibrosis is rapidly expanding as new insights highlight novel
mechanisms that influence fibroblast biology and likely promote aberrant and chronic …

Pulmonary hypertension (PH) results in increased morbidity and mortality in patients with
interstitial lung disease (ILD). Early recognition of PH in this population is essential for …

Pulmonary hypertension (PH) due to chronic lung disease is associated with a poor
prognosis, regardless of the underlying respiratory condition. Updated PH guidelines …

When overt pulmonary hypertension arises in interstitial lung disease (ILD), it contributes to
exercise intolerance. We sought to determine the functional significance of abnormal …